Growth Metrics

Madrigal Pharmaceuticals (MDGL) Net Income (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Madrigal Pharmaceuticals 14.44 Bn 14.20 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -57.89%
Dec 31, 2025 47.40%
Sep 30, 2025 -163.07%
Jun 30, 2025 42.33%
Mar 31, 2025 -23.26%
Dec 31, 2024 44.45%
Sep 30, 2024 29.62%
Jun 30, 2024 -3.00%
Mar 31, 2024 -31.51%
Dec 31, 2023 -13.63%
Sep 30, 2023 -15.08%
Jun 30, 2023 -11.58%
Mar 31, 2023 10.49%
Dec 31, 2022 -5.80%
Sep 30, 2022 -14.80%
Jun 30, 2022 -22.97%
Mar 31, 2022 10.89%
Dec 31, 2021 -2.30%
Sep 30, 2021 -2.35%
Jun 30, 2021 -16.72%
Mar 31, 2021 10.66%
Dec 31, 2020 -2.00%
Sep 30, 2020 -18.00%
Jun 30, 2020 -35.94%
Mar 31, 2020 -30.26%
Dec 31, 2019 -29.45%
Sep 30, 2019 -8.78%
Jun 30, 2019 -30.63%
Mar 31, 2019 -31.42%
Dec 31, 2018 -34.81%
Sep 30, 2018 -27.81%
Jun 30, 2018 -4.65%
Mar 31, 2018 26.81%
Dec 31, 2017 -2.74%
Sep 30, 2017 -1.39%
Jun 30, 2017 -39.14%
Mar 31, 2017 22.13%
Dec 31, 2016 45.11%
Sep 30, 2016 -391.11%
Jun 30, 2016 -59.66%
Mar 31, 2016 83.01%
Dec 31, 2015 -485.39%
Sep 30, 2015 90.91%
Jun 30, 2015 4.38%
Mar 31, 2015 -1.74%
Dec 31, 2014 -1.93%
Sep 30, 2014 10.41%
Jun 30, 2014 5.40%
Mar 31, 2014 2.50%
Dec 31, 2013 -7.32%
Sep 30, 2013 1.19%
Jun 30, 2013 -9.93%
Mar 31, 2013 -14.37%
Dec 31, 2012 -20.85%
Sep 30, 2012 -2.57%
Jun 30, 2012 2.86%
Mar 31, 2012 -40.10%
Dec 31, 2011 15.64%
Sep 30, 2011 -1.86%
Jun 30, 2011 -9.66%
Mar 31, 2011 -29.22%
Dec 31, 2010 14.02%
Sep 30, 2010 -13.09%